drugset / Trial / NCT00238849
Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the response rate to treatment with oxaliplatin and Navelbine in patients with previously treated NSCLC. Oxaliplatin and Navelbine have not been clinically evaluated yet. However, Navelbine has been safely administered with other platinum compounds.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Navelbine | Unknown | — | Intravenous |
| Subject | Oxaliplatin | Small molecule | — | Intravenous |
Indications
No indication recorded.